(Salt Lake City, UT) – The Utah Department of Health (UDOH) is encouraged by today’s news that the U.S Food and Drug Administration (FDA) has authorized the Pfizer-BioNTech COVID-19 vaccine to include adolescents 12 through 15 years of age.
As is the case with all vaccines, the UDOH recommends providers wait for final guidance from the CDC’s Advisory Committee on Immunization Practices (ACIP) prior to administering COVID-19 vaccine to anyone ages 12-15 years.
ACIP is currently scheduled to meet this Wednesday, May 12, and is expected to issue its recommendation during the meeting. Individual providers will determine how quickly they can begin administering vaccine following ACIP’s guidance.
“There are approximately 215,000 Utah children in this age group and expanding vaccine access to them will push us even closer to the finish line in our battle against COVID-19,” said Dr. Michelle Hofmann, deputy director of the UDOH. “Data presented by Pfizer indicate its vaccine is highly effective at preventing COVID-19 in this age group. In fact, none of the clinical trial participants who received the vaccine ever became infected with COVID-19.”